|
International Journal of Reproductive BioMedicine
Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences of Yazd
ISSN: 1680-6433 EISSN: 2008-2177
Vol. 6, Num. 2, 2008, pp. 51-55
|
Iranian Journal of Reproductive Medicine Vol. 6, No. 2, Spring, 2008, pp. 51-55
Comparison of coasting with Cabergoline administration
for prevention of early severe OHSS in ART cycles
Abbas Aflatoonian1 M.D., Sedigheh Ghandi 2
M.D., Nasim Tabibnejad 1 M.D.
1Research and Clinical Center for Infertility, Yazd
University of Medical Sciences, Yazd, Iran.
2Department of Obstetrics and Gynecology, Sabzevar
University of Medical Sciences, Sabzevar, Iran.
Correspondence
Author: Abbas Aflatoonian, Research and Clinical Center for Infertility, 2 Bouali
Ave, Safaeyeh, Yazd, Iran. E-mail:aflatoonian@yazdivf.org
Received:
12 March 2008; accepted: 22 June 2008
Code Number: rm08009
Abstract
Background: One of the major and life-threatening side effects of Assisted Reproductive
Technique (ART) is ovarian hyperstimulation syndrome (OHSS). The available data
however, have been showed that both Cabergoline (anti VEGF) and coasting reduce
the severity of OHSS.
Objective: We aimed to compare coasting and Cabergoline administration in prevention of
severe OHSS.
Materials and
Methods: A total of 60 IVF/ICSI cycles were selected. Patients at risk of
developing OHSS were divided into two groups as patient's convenience. For 30
patients in coasting group, exogenous gonadotropins were withheld to allow E2
to decrease while GnRH-a was maintained. Then 10,000 unit hCG was
administrated and oocyte retrieval was performed 36 hours later. In Cabergoline
group, 30 patients were administered with 0.5mg Cabergoline tablet on day of
hCG injection, continued for 8 days.
Results: The mean number of retrieved, good quality, mature oocytes and the mean number
of embryos were significantly different in two groups (p<0.05). The clinical
pregnancy rate was 13.3% in coasting and 26.7% in Cabergoline group that was
not significantly different (p>0.05). The incidence of severe OHSS was
similar in two groups.
Conclusion: The Cabergoline was as effective as coasting in the prevention of early severe
OHSS in high risk patients, but yielded more retrieved oocytes.
Key words: Cabergoline,
Coasting, OHSS, ART.
Introduction
The most serious and potentially life threatening
iatrogenic complication of controlled ovarian hyperstimulation (COH) is a
severe form of ovarian hyperstimulation syndrome (OHSS) (1, 2). It complicates
less than 0.5-2% of In Vitro Fertilization (IVF) cycles (3) which cause
mortality in 1/45000 1/50000per infertile
women receiving gonadotrophins (4). OHSS has been treated empirically over the
years, because it is pathophysiology remained unknown.
The risk of OHSS increases with high serum E2 levels and a large number of ovarian follicles,
because the granulosa cells might secret not only sex steroids but also the
vasoactive substances responsible for OHSS (1). Complications rarely manifest
before the administration of human chorionic gonadotropin (hCG) to induce the
final oocyte maturation .Vascular endothelial growth factor (VEGF) is the most
important mediator of hCG dependent ovarian angiogenesis. VEGF not only
stimulates new blood vessel development in ovary, but also induces vascular hyper
permeability by interacting with VEGF receptor 2 (5, 6). Once the syndrome
occurs, little can be done to change the course of events, only supportive
measures can be performed, however the definite and useful method in this stage
is cycle cancelling or preventing of hCG administration. Many methods have been
tried to prevent the syndrome. The appropriate stimulation protocol and
gonadotropin needs to be selected (7). Unilateral ovarian follicular aspiration
prior to the administration of hCG was successful in some investigations (8).
In our previous study, aspiration of half of follicles before hCG
administration reduced the risk of severe OHSS (9). Cryopreservation of all
embryos has no effect on the syndrome occurring in the days immediately
following oocyte retrieval, but eliminates the risk of early pregnancy OHSS. It
takes a good success rate at subsequent frozen thawed transfers (10). Another
method for preventing OHSS is coasting approach. Withholding gonadotropin
adminis-tration has been employed in ovulation induction cycles to prevent
excessive response (11-13). This was used in gonadotropin-releasing hormone
analogue-treated patients (14). Recently a dopamine agonist, Cabergoline has
been used successfully for prevention of severe OHSS (15).
The purpose of this prospective study was two folds:
1) to assess the effect of Cabergoline on cycle outcome and preventing severe
OHSS and 2) to compare it with popular coasting method. To our knowledge, this
is the first study which compares coasting with a pathophysiological approach.
Materials and methods
Patients
The study was approved by ethical committee of
Research and Clinical Center for Infertility, Yazd University of Medical Sciences
and it is was supported by a grant from the Research Deputy of Yazd University
of Medical Sciences. The written informed consent was given from the patients.
Among couples who underwent IVF or ICSI cycles because of tubal, male, ovarian,
unexplained, endometriosis and both male and female factors, 60 women at risk
of developing OHSS were included in this study. The definition of risk was: the
presence of pre- ovulatory follicles ≥ 20 in both ovaries, most of
follicles were > 15 mm and at least 3 follicles ≥ 18mm were present.
The E2 level was ≥ 2500 pg/ml.
Stimulation protocol
All women were down regulated according to the
long protocol with Gonadotropin-releasing hormone
analogue (GnRH-a) subcutaneously (Buserelin, Hoechst, Germany). Then,
daily administration of human menopausal gonadotropin (hMG) (Menogon, Ferring,
Germany) was added. Serum E2 concentrations were measured with Enzyme-Linked Immunosorbent Assay (ELISA, DRG
Instruments GmbH, Germany) at the Yazd Research and Clinical Center for
Infertility. Patients at risk of developing OHSS, who did not have a tendency to
cancel their cycle, were divided into two groups as patient's convenience.
Group A (coasting group): gonadotropins were withheld (while GnRHa was
maintained), until the serum level of E2 started to decline. In
group B (Cabergoline group): hCG was administered and the patients received 0.5
mg per day Cabergoline orally from the day of hCG for 8 days. Luteal phase was
supported by administration of progesterone in oil 100mg per day for 14 days
and was continued if pregnancy occurred. Embryo culture and Embryo Transfer
(ET) procedure were carried out in both groups in a similar fashion. Patients
were monitored every 48 h from the day of hCG until the day 8 for the presence
of symptoms and signs of severe OHSS and Hemoglobin (Hb) and Hematocrit (HCT) was measured. Clinical pregnancy
was defined as the presence of gestational sac or cardiac activity 3 weeks
after ET.
Statistical analysis
The Statistical Package for the Social Sciences
15.0 software was used to analyse data of all randomized patients. To control
for the non-normal distribution of the data, Mann-whitney and X2 tests
were used when appropriate, for the small number of cases, Fishers exact test
was used for the comparison of frequencies. A p<0.05 was considered
statistically significant.
Results
Between July 2006 and July 2007, we studied 60
patients at Yazd Research and Clinical Center for Infertility which is a famous
referral University center in Iran. In total, 30 patients in coasting and 30
patients in Cabergoline group were evaluated. The mean age was 28.37±3.2 years
in coasting and 29.63±4.4 years in Cabergoline group (p=0.209). The mean duration
of infertility was 8.66±3.55 years in coasting and 8.16±4.8 years in Cabergoline
group (p=0.650). The mean serum E2 level on day of hCG was
3035.40±1105 pg/ml in coasting and 3012.86 ± 512 pg /ml in Cabergoline group (p=0.232).
There was no significant differences in etiology of infertility between two
groups (p=0.542). The mean duration of coasting in coasting group was 3.20±0.76
days (2-5 days). One patient in coasting and one patient in Cabergoline group
had very bad quality embryos and lead to cycle cancellation before ET. The mean
number of retrieved oocytes (p=0.001), good quality oocytes (p=0.002),
metaphase II oocytes (p=0.0001) and the mean number of embryos obtained was
significantly higher in Cabergoline group than coasting group (p=0.020). The
percentage of good quality oocytes (the number of good quality oocytes per
number of oocytes retrieved ×100) was higher in coasting group (p=0.061). The
percentage of metaphase II oocytes (the number of metaphase II oocytes per
number of oocytes retrieved ×100) was significantly higher in coasting group (p=0.001).
Fertilization rate was also significantly higher in coasting than Cabergoline
group (p=0.001). One patient in coasting group had very bad oocytes and the
cycle was cancelled. The quality of embryos was similar in both group (p=0.600).
The clinical pregnancy rate per ovum pickup was higher in Cabergoline than
coasting group (p=0.285). A total of 4 pregnancies occurred in coasting group.
All pregnancies were singleton and there were 2 early miscarriages in coasting
group (before 8 week of gestation). Eight pregnancies occurred in Cabergoline
group, 2 of these were twin pregnancies. Implantation rate was higher in Cabergoline
than coasting group, but the difference was not significant (p=0.060). Four
patients in coasting group and 5 patients in Cabergoline group developed severe
OHSS and were hospitalized. One patient from each group required parasynthesis
and for remaining patients infusion of normal saline was performed. The
incidence of severe OHSS was similar in coasting (13.3%) and in Cabergoline (16.7%)
group (p=0.100).
Table I. Basic
characteristics and early results of patients at risk of OHSS in two groups.
|
Coasting (n=30)
|
Cabergoline (n=30)
|
p-value
|
Age (years)
|
28.37(3.20)
|
29.63(4.42)
|
0. 209a
|
Duration
of infertility (years)
|
8.60(3.50)
|
8.1(4.8)
|
0.650a
|
E2 on day of hCG (pg/ml)
|
3035(1105.0)
|
3012(512)
|
0.232b
|
Number of retrieved oocytes
|
6.47(2.64)
|
12.60(5.26)
|
0.001b
|
Number of good quality oocytes
|
4.50(2.51)
|
7.27(3.76)
|
0.002b
|
Number of metaphase II oocytes
|
6.17(2.96)
|
10.17(4.06)
|
0.0001 b
|
Number of embryos obtained
|
5.07(2.44)
|
7.20(3.60)
|
0.020b
|
Number of embryos transferred
|
2.37(0.66)
|
2.30(0.83)
|
0.774 b
|
Score of embryos
|
17.23(3.52)
|
16.63(4.42)
|
0.600b
|
Percentage of good quality oocytes
|
66.98(23.34)
|
55.82(21.91)
|
0.061a
|
Percentage of metaphase II oocytes
|
95.00(20.12)
|
81.96(18.75)
|
0.001b
|
Data are presented as mean(SD); ausing
independent samples t-test; busing Mann- Whitney test.
Table II. Clinical outcomes of patients at risk of OHSS in two
groups.
|
Coasting (n=30) |
Cabergoline (n=30) |
p-value |
Fertilization rate a |
79.07(21.95) |
59.94±18.03 |
0.001b |
Implantation rate (%)c |
4/71)5.6) |
10/69(14.4) |
0.060d |
Clinical pregnancy rate (%)c |
4/30(13.3) |
8/30(26.7) |
0.285d |
Severe OHSS(%)c |
4/30(13.3)
|
5/30(16.7) |
0.100d |
aData are
presented as mean(SD); busing independent samples t-test; cdata
are presented as n/N (%): n, number of patients with the quality, N, total
number of the participants in this group; dusing Pearson chi-square
test with continuity correction.
Discussion
OHSS is the major complication of ovarian
stimulation and its most severe form can even threaten the patients life.
Several strategies for preventing the syndrome have been described. The safest
strategy is to cancel the cycle. However, it should be considered that any form
of cancellation is associated with emotional and financial costs to the couple
involved. It is also possible to avoid embryo transfer and freeze all embryos
(16). Another approach for the prevention of OHSS is follicular aspiration
prior to hCG administration (8). One popular method for reducing the risk of
syndrome is withholding gonadotropin administration and postponing the hCG
injection, while continuing GnRH agonists. This modality has been termed
coasting (17). In our previous study, no significant difference was observed in
terms of pregnancy rate and severe OHSS when coasting was compared with
follicular aspiration (18).
Recently, Cabergoline has been successfully used
for high risk patients and has reduced the severity of OHSS (19). It has been
shown that Cabergoline could reverse increased vascular permeability in
hyperstimulated animals by inhibition of VEGFR2 phosphorylation. In
animal studies, it has been shown that low dose Cabergoline blocked some
specific VEGFR2 phosphorylation sites. Therefore, changes in VEGFR2
induced by low dose Cabergoline reversed the occurrence of increased vascular
permeability without altering angiogenesis (20). The use of Cabergoline for
prevention of OHSS neither reduced pregnancy nor implantation rate (19).
Coasting has proven to be an effective method to
reduce the development of severe OHSS in high risk patients. It has been
suggested that withholding gonadotropins may increase the rate of granulosa
cell apoptosis (21). This may cause atresia of a large number of small
follicles, thus leading to a reduction in serum E2 concentration and
vasoactive mediators (22). The decreased serum FSH concentrations down
regulates the LH receptors of the follicles, thus making fewer oocytes available
for maturation by hCG. At ovarian puncture, oocytes which fail to undergo the
final maturation, stick to the follicle wall and are not retrieved. The end
result is reduction of chemical mediators that cause hyperpermeability and a
reduction in the number of oocytes retrieved (23).
In our study like the studies mentioned above, the
number of retrieved oocytes, good quality and mature oocytes, were significantly
lower in coasting group. But the percentage of mature oocytes and the
fertilization rate were significantly higher in coasting than Cabergoline group.
Clinical pregnancy and implantation rate were higher in Cabergoline group.
Since, oocyte quality was not affected by
coasting; it seems that the receptivity of the endometrium was affected. Our
results, like those of Tortoriello et al (1998) and Ulug et al
(2002) suggest that coasting for > 3 days may reduces the implantation and
pregnancy rates (21,24). However, Cabergoline has no teratogenic effects on
fetus (25, 26).
In conclusion, coasting is a popular and
effective method to reduce OHSS rates, but our study showed that this procedure
appears to be associated with a reduced oocyte retrieval rate, and also
reduced endometrial receptivity. Cabergoline administration was as effective as
coasting for prevention of early severe OHSS. This method is a
pathophysiological approach, time-saving and lead to higher pregnancy rate than
coasting. However further studies with more cases are needed.
References
- Whelan J, Vlahos N. The ovarian hyperstimulation
syndrome. Fertil Steril 2000; 73:883-896.
- Roest J. Severe OHSS: An
'epidemic' caused by doctors. Hum Reprod 1999; 14: 2183.
- Bergh PA, Navot D. Ovarian
hyperstimulation syndrome: a review of pathophysiology. J Assist
Reprod Genet 1992; 9:429- 438.
- Brinsden PR. Diagnosis, Prevention and management of
OHSS. Br J Obstet Gynecol 1995; 102:767-772.
- Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M,
Heldin CH. Different signal transduction properties
of KDR and Flt1, two receptors for vascular endothelial growth factor. J
Biol Chem 1994; 26:26988-26995.
- Verheul HM, Hoekman K, Jorna AS, Smit EF, Pinedo HM.
Targeting vascular endothelial growth factor blockage: ascites and pleural
effusion formation. Oncologist 2000; 5:s45-s50.
- Delvigne A, Rozenberg S. Epidemiology
and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum
Reprod Update 2002; 8:559 577.
- Egbase PE, Makhseed M, Al Sharhan M, Grudzinskas JG.
Timed unilateral follicular aspiration prior to administration of human
chorionic gonadotropin for the prevention of severe ovarian hyperstimulation
syndrome in in-vitro fertilization:a prospective randomized study. Hum
Reprod 1997; 12:26032606.
- Aflatoonian A, Dehghani-Firouzabadi R, Kalantar SM,
Solimani M, Karymzadeh-Mibodi MA, Taheripanah R, et al. The role of aspiration
of half of ovarian follicles prior to administration of hCG or GnRH-a for
prevention of severe OHSS in ART programs. Middle East Fertility Society
Journal 2000; 5:73-75.
- Queenan JTJr, Veeck LL, Toner JP, Oehninger S, Muasher
SJ. Cryopreservation of all prezygotes in patients
at risk of severe hyperstimulation does not eliminate the syndrome, but the
chances of pregnancy are excellent with subsequent frozen-thaw transfers. Hum
Reprod 1997; 12:15731576.
- Rabinovici J, Kushnir O, Shalev J, Goldenberg M,
Blankstein J. Rescue of menotrophin cycles prone to develop ovarian
hyperstimulation. Br J Obstet Gynecol 1987; 94:10981102.
- Urman B, Pride SM, Yuen BH. Management of
overstimulated gonadotrophin cycles with a controlled drift period. Hum
Reprod 1992; 7:213217.
- Schenker JG .Prevention and treatment of ovarian
hyperstimulation. Hum Reprod 1993; 8:653659.
- BenNun I, Shulman A, Ghetler Y, Shilon M, Kaneti H ,
Beyth Y. The significance of 17 beta-estradiol levels
in highly responding women during ovulation induction in IVF treatment: its
impact and prognostic value with respect to oocyte maturation and treatment
outcome. J Assist Reprod Genet 1993; 10:213-215.
- Alvarez C, Bosch E, Melo MAB, Fernandez-Sanchez M,
Munoz EA, Remohi J, et al. The dopamine agonist cabergoline prevents
moderate-severe early ovarian hyperstimulation syndrome (OHSS) in high-risk
patients.Hum Reprod 2006; 21: i96.
- Tiitinen A, Husa LM, Tulppala M, Simberg N, Seppala M.
The effect of cryopreservation in prevention of ovarian hyperstimulation
syndrome. Br J Obstet Gynaecol 1995; 102:326-329.
- Sher G, Salem R, Feinman M, Dodge S, Zouves C, Knutzen
V. Eliminating the risk of life-endangering
complications following overstimulation with menotropin fertility agents: a
report on women undergoing in vitro fertilization and embryo transfer. Obstet
Gynecol 1993; 81:10091011.
- Aflatoonian A, Mahani IM, Tabibnejad N. Comparison of
coasting with aspiration half of follicles before HCG injection for prevention
of OHSS in ART cycles. Hum Reprod 2006; 21: s137.
- Alvarez C, Gonzalez S,Crespo
J, Simón C, Remohı́ J, Pellicer A. Cabergoline (Cb2) administration
to prevent ovarian hyperstimulation syndrome (OHSS) in IVF ICSI does not reduce
implantation and pregnancy rates. Fertil Steril 2006; 86: s337.
- Gomez R, Gonzalez M, Zimmermann R,Remohi J, Simon C , Pellicer A. Segregation of the
antiapermeability and the antiangiogenic effects derived from VEGFR2 blockade
by cabergoline. A specific non-toxic approach to treat OHSS. Fertil Steril 2006; 86: s45.
- Tortoriello DV, McGovern PG, Colon JM, Skurnick JH,
Lipetz K, Santoro N. "Coasting" does not
adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients. Fertil Steril 1998;
69: 454-460.
- Enskog A, Henriksson M, Unander M, Nilsson L,
Brännström M. Prospective study of the clinical and laboratory parameters of
patients in whom ovarian hyperstimulation syndrome developed during controlled
ovarian hyperstimulation for in vitro fertilization. Fertil Steril 1999;
71: 808-814.
- Waldenstrom U, Kahn J, Marsk L, Nilsson S. High pregnancy rates and successful prevention of
severe ovarian hyperstimulation syndrome by prolonged coasting of very hyperstimulated patients: a multicentre study. Hum
Reprod 1999; 14:294-297.
- Ulug U, Bahceci M, Erden HF, Shalev E, Ben-Shlomo. The
significance of coasting duration during ovarian stimulation for conception in
assisted fertilization cycles. Hum Reprod 2002; 17: 310-313.
- Speroff L, Fritz MA. Induction of ovulation. In:
Clinical Gynecologic Endocrinology and Infertility. Los Angeles. Lippincott
Williams & Wilkins 2005: 1175-1214.
- Crosignani PG. Management of hyperprolactiaemic
infertility. In: Ovulation induction. Paris. ELSEVIER, 2002: 79-86.
© Copyright 2008 - Iranian Journal of Reproductive Medicine
|